129 related articles for article (PubMed ID: 14557015)
21. Ha-ras oncogene mutation associated to progression of papillomavirus induced lesions of uterine cervix.
Alonio LV; Picconi MA; Dalbert D; Mural J; Bartt O; Bazán G; Dominguez M; Teyssié AR
J Clin Virol; 2003 Aug; 27(3):263-9. PubMed ID: 12878090
[TBL] [Abstract][Full Text] [Related]
22. The role of p53 inactivation in human cervical cell carcinoma development.
Miwa K; Miyamoto S; Kato H; Imamura T; Nishida M; Yoshikawa Y; Nagata Y; Wake N
Br J Cancer; 1995 Feb; 71(2):219-26. PubMed ID: 7841033
[TBL] [Abstract][Full Text] [Related]
23. Microsatellite instability, expression of hMSH2 and hMLH1 and HPV infection in cervical cancer and their clinico-pathological association.
Chung TK; Cheung TH; Wang VW; Yu MY; Wong YF
Gynecol Obstet Invest; 2001; 52(2):98-103. PubMed ID: 11586036
[TBL] [Abstract][Full Text] [Related]
24. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix.
Ferguson AW; Svoboda-Newman SM; Frank TS
Mod Pathol; 1998 Jan; 11(1):11-8. PubMed ID: 9556417
[TBL] [Abstract][Full Text] [Related]
25. [Human papillomavirus, human cytomegalovirus and p53 gene in cervical carcinoma].
Zhao W; Si J; Li K
Zhonghua Fu Chan Ke Za Zhi; 1995 Nov; 30(11):654-7. PubMed ID: 8745488
[TBL] [Abstract][Full Text] [Related]
26. MDM2 SNP 309 human papillomavirus infection in cervical carcinogenesis.
Nunobiki O; Ueda M; Yamamoto M; Toji E; Sato N; Izuma S; Okamoto Y; Torii K; Noda S
Gynecol Oncol; 2010 Sep; 118(3):258-61. PubMed ID: 20538323
[TBL] [Abstract][Full Text] [Related]
27. p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status.
Busby-Earle RM; Steel CM; Williams AR; Cohen B; Bird CC
Br J Cancer; 1994 Apr; 69(4):732-7. PubMed ID: 8142262
[TBL] [Abstract][Full Text] [Related]
28. Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix.
Khouadri S; Villa LL; Gagnon S; Koushik A; Richardson H; Matlashewski G; Roger M; Ferenczy AS; Franco EL; Coutlée F
Int J Cancer; 2007 Dec; 121(12):2674-81. PubMed ID: 17708553
[TBL] [Abstract][Full Text] [Related]
29. FHIT alterations in cancerous and non-cancerous cervical epithelium.
Yoshino K; Enomoto T; Nakamura T; Sun H; Ozaki K; Nakashima R; Wada H; Saitoh J; Watanabe Y; Noda K; Murata Y
Int J Cancer; 2000 Jan; 85(1):6-13. PubMed ID: 10585575
[TBL] [Abstract][Full Text] [Related]
30. E7 proteins from oncogenic human papillomavirus types transactivate p73: role in cervical intraepithelial neoplasia.
Brooks LA; Sullivan A; O'Nions J; Bell A; Dunne B; Tidy JA; Evans DJ; Osin P; Vousden KH; Gusterson B; Farrell PJ; Storey A; Gasco M; Sakai T; Crook T
Br J Cancer; 2002 Jan; 86(2):263-8. PubMed ID: 11870517
[TBL] [Abstract][Full Text] [Related]
31. EGFR Promoter Methylation, EGFR Mutation, and HPV Infection in Chinese Cervical Squamous Cell Carcinoma.
Zhang W; Jiang Y; Yu Q; Qiang S; Liang P; Gao Y; Zhao X; Liu W; Zhang J
Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):661-6. PubMed ID: 25789535
[TBL] [Abstract][Full Text] [Related]
32. Frequent detection of human papilloma viruses in cervical dysplasia by PCR single-strand DNA-conformational polymorphism analysis.
Nakagawa H; Sugano K; Fujii T; Kubushiro K; Tsukazaki K; Nozawa S
Anticancer Res; 2002; 22(3):1655-60. PubMed ID: 12168850
[TBL] [Abstract][Full Text] [Related]
33. [The detection of p53 gene and HPV16 oncogene in cervical carcinoma].
Sun Y; Si L
Zhonghua Bing Li Xue Za Zhi; 1995 Feb; 24(1):29-32. PubMed ID: 7781112
[TBL] [Abstract][Full Text] [Related]
34. CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer.
Zhang Z; Borecki I; Nguyen L; Ma D; Smith K; Huettner PC; Mutch DG; Herzog TJ; Gibb RK; Powell MA; Grigsby PW; Massad LS; Hernandez E; Judson PL; Swisher EM; Crowder S; Li J; Gerhard DS; Rader JS
Cancer Res; 2007 Dec; 67(23):11202-8. PubMed ID: 18056445
[TBL] [Abstract][Full Text] [Related]
35. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.
Vinokurova S; Wentzensen N; Einenkel J; Klaes R; Ziegert C; Melsheimer P; Sartor H; Horn LC; Höckel M; von Knebel Doeberitz M
J Natl Cancer Inst; 2005 Dec; 97(24):1816-21. PubMed ID: 16368943
[TBL] [Abstract][Full Text] [Related]
36. The origin and molecular characterization of adenoid basal carcinoma of the uterine cervix.
Jones MW; Kounelis S; Papadaki H; Bakker A; Swalsky PA; Finkelstein SD
Int J Gynecol Pathol; 1997 Oct; 16(4):301-6. PubMed ID: 9421067
[TBL] [Abstract][Full Text] [Related]
37. Proteomic identification of potential biomarkers for cervical squamous cell carcinoma and human papillomavirus infection.
Qing S; Tulake W; Ru M; Li X; Yuemaier R; Lidifu D; Rouzibilali A; Hasimu A; Yang Y; Rouziahong R; Upur H; Abudula A
Tumour Biol; 2017 Apr; 39(4):1010428317697547. PubMed ID: 28443473
[TBL] [Abstract][Full Text] [Related]
38. Analysis and clinical implications of K-ras gene mutations and infection with human papillomavirus types 16 and 18 in primary adenocarcinoma of the uterine cervix.
Tenti P; Romagnoli S; Silini E; Pellegata NS; Zappatore R; Spinillo A; Zara C; Ranzani GN; Carnevali L
Int J Cancer; 1995 Feb; 64(1):9-13. PubMed ID: 7665253
[TBL] [Abstract][Full Text] [Related]
39. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
40. Genetic alterations in the K-Ras gene influence the prognosis in patients with cervical cancer treated by radiotherapy.
Wegman P; Ahlin C; Sorbe B
Int J Gynecol Cancer; 2011 Jan; 21(1):86-91. PubMed ID: 21330833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
